PDS Biotechnology Corp (PDSB) bonds
PDSBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 0/30
$0.89−0.03 (-3.28%)
Close on Nov 17, 2026Market cap $50.03MP/E –Yield –
Debt
Borrowings on the balance sheet, Jun 30, 2026
PDS Biotechnology reports no long-term debt line
Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.
When the debt comes due
Principal repayments of long-term debt by fiscal year, as scheduled at Dec 31, 2017
From the debt maturity table in the annual report (filing). “Later” is everything due after year five.
Notes and loans outstanding
As tagged in PDS Biotechnology's 10-Q for the period ended Jun 15, 2026
| Issue | Coupon | Matures | Amount issued |
|---|---|---|---|
| Senior Secured Convertible Debentures Convertible at $3 a share | Floating + 5.00% | Apr 30, 2028 | $22.20M |
| Promissory Note | 10.00% | – | $6.00M |
Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-Q.
See a number that looks wrong?